APAC Veterinary Pain Management Market - Industry Trends and Forecast to 2031

TABLE OF CONTENTS

1 INTRODUCTION 26

• 1.1 OBJECTIVES OF THE STUDY 26
• 1.2 MARKET DEFINITION 26
• 1.3 OVERVIEW OF THE ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET 26
• 1.4 CURRENCY AND PRICING 28
• 1.5 LIMITATIONS 28
• 1.6 MARKETS COVERED 29

2 MARKET SEGMENTATION 32

• 2.1 MARKETS COVERED 32
• 2.2 GEOGRAPHICAL SCOPE 33
• 2.3 YEARS CONSIDERED FOR THE STUDY 34
• 2.4 DBMR TRIPOD DATA VALIDATION MODEL 35
• 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 38
• 2.6 MULTIVARIATE MODELLING 39
• 2.7 MARKET END USER COVERAGE GRID 39
• 2.8 PRODUCT LIFELINE CURVE 40
• 2.9 DBMR MARKET POSITION GRID 41
• 2.10 VENDOR SHARE ANALYSIS 42
• 2.11 SECONDARY SOURCES 43
• 2.12 ASSUMPTIONS 43

3 EXECUTIVE SUMMARY 44

4 PREMIUM INSIGHTS 47

• 4.1 PESTEL ANALYSIS 48
• 4.2 PORTER'S FIVE FORCES 49
• 4.3 BRAND REVENUE ANALYSIS 50

5 MARKET OVERVIEW 51

• 5.1 DRIVERS 53
  • 5.1.1 INCREASING PET OWNERSHIP 53
  • 5.1.2 ADVANCEMENTS IN VETERINARY MEDICINE 53
  • 5.1.3 GROWING INCIDENCES OF PET DISEASES 54
  • 5.1.4 INCREASED GOVERNMENT PROJECTS TO ENHANCE ANIMAL CARE 54
• 5.2 RESTRAINTS 55
  • 5.2.1 INCREASING PET CARE COSTS 55
  • 5.2.2 STRICT REGULATORY GUIDELINES 55 
• 5.3 OPPORTUNITIES 56
  • 5.3.1 RISING R&D ACTIVITIES AND PRODUCT APPROVAL FOR VETERINARY PAIN MANAGEMENT 56
  • 5.3.2 RISING POPULARITY OF NON- CONVENTIONAL TREATMENT APPROACHES 57
  • 5.3.3 TECHNOLOGICAL ADVANCEMENTS 57
• 5.4 CHALLENGES 58
  • 5.4.1 LIMITED AVAILABILITY OF VETERINARIANS 58
  • 5.4.2 RESISTANCE TO MEDICATIONS 58

6 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE 59

• 6.1 OVERVIEW 60
• 6.2 ANALGESICS 61
  • 6.2.1 ANTI- INFLAMMATORY (NSAIDS) 61
    • 6.2.1.1 CARPROFEN 62
    • 6.2.1.2 MELOXICAM 62
    • 6.2.1.3 PHENYLBUTAZONE 62
    • 6.2.1.4 ACETAMINOPHEN 62
    • 6.2.1.5 FIROCOXIB 62
    • 6.2.1.6 DERACOXIB 62
    • 6.2.1.7 OTHERS 63
  • 6.2.2 OPIOIDS 63
    • 6.2.2.1 MU AGONISTS 63
      • 6.2.2.1.1 METHADONE 64
      • 6.2.2.1.2 MEPERIDINE 64
      • 6.2.2.1.3 MORPHINE 64
      • 6.2.2.1.4 OXYMORPHONE 64
      • 6.2.2.1.5 OTHERS 64
    • 6.2.2.2 PARTIAL MU AGONIST 64
      • 6.2.2.2.1 BUPRENORPHINE 64
      • 6.2.2.2.2 OTHERS 65
    • 6.2.2.3 KAPPA AGONIST MU ANTAGONIST 65
      • 6.2.2.3.1 BUTORPHANOL 65
      • 6.2.2.3.2 OTHERS 65
• 6.3 CORTICOSTEROIDS 66
  • 6.3.1 DEXAMETHASONE 66
  • 6.3.2 PREDNISOLONE 66
  • 6.3.3 PREDNISONE 66
  • 6.3.4 OTHERS 67
• 6.4 ALPHA 2 AGONISTS 67 

7 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE 68

• 7.1 OVERVIEW 69
• 7.2 BRANDED 70
• 7.3 GENERIC 70

8 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE 71

• 8.1 OVERVIEW 72
• 8.2 PRESCRIPTION BASED 73
• 8.3 OTC 73

9 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE 74

• 9.1 OVERVIEW 75
• 9.2 COMPANION ANIMAL 76
  • 9.2.1 CANINE 77
  • 9.2.2 EQUINE 77
  • 9.2.3 FELINE 77
  • 9.2.4 OTHERS 77
• 9.3 PRODUCTION ANIMAL 77
  • 9.3.1 CATTLE 78
  • 9.3.2 SWINE 78
  • 9.3.3 POULTRY 78
  • 9.3.4 FISH 78
  • 9.3.5 OTHERS 78

10 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE 79

• 10.1 OVERVIEW 80
• 10.2 CHRONIC PAIN 81
• 10.3 ACUTE PAIN 82
• 10.4 POST OPERATIVE PAIN 82
• 10.5 DENTAL PAIN 83

11 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE 84

• 11.1 OVERVIEW 85
• 11.2 SOLID 86
  • 11.2.1 TABLET 86
  • 11.2.2 POWDER 87
  • 11.2.3 OTHERS 87 
• 11.3 LIQUID 87
  • 11.3.1 SOLUTION 87
  • 11.3.2 SYRUP 88
  • 11.3.3 SUSPENSION 88
  • 11.3.4 OTHERS 88
• 11.4 SEMI SOLID 88
  • 11.4.1 GEL 89
  • 11.4.2 CREAM 89
  • 11.4.3 OTHERS 89

12 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION 90

• 12.1 OVERVIEW 91
• 12.2 PARENTERAL 92
• 12.3 ORAL 93
• 12.4 TOPICAL 93

13 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY END USER 94

• 13.1 OVERVIEW 95
• 13.2 VETERINARY HOSPITALS 96
• 13.3 VETERINARY CLINICS 97
• 13.4 PET SHOPS 97
• 13.5 ANIMAL FARMS 98
• 13.6 ACADEMIC & RESEARCH INSTITUTES 98
• 13.7 OTHERS 99

14 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY GEOGRAPHY 100

• 14.1 ASIA PACIFIC 101
  • 14.1.1 CHINA 109
  • 14.1.2 AUSTRALIA 116
  • 14.1.3 INDIA 123
  • 14.1.4 JAPAN 130
  • 14.1.5 SINGAPORE 137
  • 14.1.6 INDONESIA 144
  • 14.1.7 MALAYSIA 151
  • 14.1.8 NEW ZEALAND 158
  • 14.1.9 SOUTH KOREA 165
  • 14.1.10 VIETNAM 172
  • 14.1.11 THAILAND 179
  • 14.1.12 PHILIPPINES 186
  • 14.1.13 TAIWAN 193
  • 14.1.14 REST OF ASIA-PACIFIC 200

15 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, COMPANY LANDSCAPE 201

• 15.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 201

16 SWOT ANALYSIS 202

17 COMPANY PROFILE 203

• 17.1 ZOETIS SERVICES LLC 203
  • 17.1.1 COMPANY SNAPSHOT 203
  • 17.1.2 COMPANY SHARE ANALYSIS 203
  • 17.1.3 PRODUCT PORTFOLIO 204
  • 17.1.4 RECENT DEVELOPMENTS 204
• 17.2 ELANCO 205
  • 17.2.1 COMPANY SNAPSHOT 205
  • 17.2.2 REVENUE ANALYSIS 205
  • 17.2.3 COMPANY SHARE ANALYSIS 206
  • 17.2.4 PRODUCT PORTFOLIO 206
  • 17.2.5 RECENT DEVELOPMENT 206
• 17.3 MERCK & CO., INC. 207
  • 17.3.1 COMPANY SNAPSHOT 207
  • 17.3.2 REVENUE ANALYSIS 207
  • 17.3.3 COMPANY SHARE ANALYSIS 208
  • 17.3.4 PRODUCT PORTFOLIO 208
  • 17.3.5 RECENT DEVELOPMENT 208
• 17.4 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 209
  • 17.4.1 COMPANY SNAPSHOT 209
  • 17.4.2 COMPANY SHARE ANALYSIS 209
  • 17.4.3 PRODUCT PORTFOLIO 210
  • 17.4.4 RECENT DEVELOPMENT 210
• 17.5 VETOQUINOL 211
  • 17.5.1 COMPANY SNAPSHOT 211
  • 17.5.2 REVENUE ANALYSIS 211
  • 17.5.3 COMPANY SHARE ANALYSIS 212
  • 17.5.4 PRODUCT PORTFOLIO 212
  • 17.5.5 RECENT DEVELOPMENTS 212
• 17.6 BIMEDA, INC. 214
  • 17.6.1 COMPANY SNAPSHOT 214
  • 17.6.2 PRODUCT PORTFOLIO 214
  • 17.6.3 RECENT DEVELOPMENT 214 
• 17.7 CEVA ANIMAL HEALTH, LLC 215
  • 17.7.1 COMPANY SNAPSHOT 215
  • 17.7.2 PRODUCT PORTFOLIO 215
  • 17.7.3 RECENT DEVELOPMENT 215
• 17.8 CHANELLE PHARMA 216
  • 17.8.1 COMPANY SNAPSHOT 216
  • 17.8.2 PRODUCT PORTFOLIO 216
  • 17.8.3 RECENT DEVELOPMENT 216
• 17.9 DECHRA PHARMACEUTICALS PLC 217
  • 17.9.1 COMPANY SNAPSHOT 217
  • 17.9.2 REVENUE ANALYSIS 217
  • 17.9.3 PRODUCT PORTFOLIO 218
  • 17.9.4 RECENT DEVELOPMENTS 218
• 17.10 DURVET ANIMAL HEALTH PRODUCTS 219
  • 17.10.1 COMPANY SNAPSHOT 219
  • 17.10.2 PRODUCT PORTFOLIO 219
  • 17.10.3 RECENT DEVELOPMENT 219
• 17.11 INOVET (A SUBSIDIARY OF ORION GROUP) 220
  • 17.11.1 COMPANY SNAPSHOT 220
  • 17.11.2 PRODUCT PORTFOLIO 220
  • 17.11.3 RECENT DEVELOPMENTS 220
• 17.12 NORBROOK 222
  • 17.12.1 COMPANY SNAPSHOT 222
  • 17.12.2 PRODUCT PORTFOLIO 222
  • 17.12.3 RECENT DEVELOPMENT 222
• 17.13 VIRBAC 223
  • 17.13.1 COMPANY SNAPSHOT 223
  • 17.13.2 REVENUE ANALYSIS 223
  • 17.13.3 PRODUCT PORTFOLIO 224
  • 17.13.4 RECENT DEVELOPMENT 224

18 QUESTIONNAIRE 225

19 RELATED REPORTS 229

LIST OF TABLES

• TABLE 1 BRAND REVENUE ANALYSIS FOR VETERINARY PAIN MANAGEMENT MARKET 50
• TABLE 2 NUMBER OF U.S. HOUSEHOLD-OWNED PET ANIMALS 53
• TABLE 3 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 61
• TABLE 4 ASIA-PACIFIC ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 61
• TABLE 5 ASIA-PACIFIC ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 61
• TABLE 6 ASIA-PACIFIC ANTI- INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 62
• TABLE 7 ASIA-PACIFIC OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 63
• TABLE 8 ASIA-PACIFIC MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 63
• TABLE 9 ASIA-PACIFIC PARTIAL MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 64
• TABLE 10 ASIA-PACIFIC KAPPA AGONIST MU ANTAGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 65
• TABLE 11 ASIA-PACIFIC CORTICOSTEROIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 66
• TABLE 12 ASIA-PACIFIC CORTICOSTEROIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 66
• TABLE 13 ASIA-PACIFIC ALPHA-2 AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 67
• TABLE 14 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 70
• TABLE 15 ASIA-PACIFIC BRANDED IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 70
• TABLE 16 ASIA-PACIFIC GENERIC IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 70
• TABLE 17 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 73
• TABLE 18 ASIA-PACIFIC PRESCRIPTION BASED IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 73
• TABLE 19 ASIA-PACIFIC OTC IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 73
• TABLE 20 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 76
• TABLE 21 ASIA-PACIFIC COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 76
• TABLE 22 ASIA-PACIFIC COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 76
• TABLE 23 ASIA-PACIFIC PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 77
• TABLE 24 ASIA-PACIFIC PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 78
• TABLE 25 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 81
• TABLE 26 ASIA-PACIFIC CHRONIC PAIN IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 81
• TABLE 27 ASIA-PACIFIC ACUTE PAIN IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 82
• TABLE 28 ASIA-PACIFIC POST OPERATIVE PAIN IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 82
• TABLE 29 ASIA-PACIFIC DENTAL PAIN IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 83
• TABLE 30 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 86
• TABLE 31 ASIA-PACIFIC SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 86
• TABLE 32 ASIA-PACIFIC SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 86
• TABLE 33 ASIA-PACIFIC LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 87
• TABLE 34 ASIA-PACIFIC LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 87
• TABLE 35 ASIA-PACIFIC SEMI SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 88
• TABLE 36 ASIA-PACIFIC SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 88
• TABLE 37 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 92
• TABLE 38 ASIA-PACIFIC PARENTERAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 92
• TABLE 39 ASIA-PACIFIC ORAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 93
• TABLE 40 ASIA-PACIFIC TOPICAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 93
• TABLE 41 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 96
• TABLE 42 ASIA-PACIFIC VETERINARY HOSPITALS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 96
• TABLE 43 ASIA-PACIFIC VETERINARY CLINICS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 97
• TABLE 44 ASIA-PACIFIC PET SHOPS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 97
• TABLE 45 ASIA-PACIFIC ANIMAL FARMS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 98
• TABLE 46 ASIA-PACIFIC ACADEMIC & RESEARCH INSTITUTES IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 98
• TABLE 47 ASIA-PACIFIC OTHERS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 99
• TABLE 48 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 101
• TABLE 49 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 102
• TABLE 50 ASIA-PACIFIC ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 102
• TABLE 51 ASIA-PACIFIC ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 102
• TABLE 52 ASIA-PACIFIC OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 103
• TABLE 53 ASIA-PACIFIC MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 103
• TABLE 54 ASIA-PACIFIC PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 103
• TABLE 55 ASIA-PACIFIC KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 104
• TABLE 56 ASIA-PACIFIC CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 104
• TABLE 57 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 104
• TABLE 58 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 105
• TABLE 59 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 105
• TABLE 60 ASIA-PACIFIC COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 105
• TABLE 61 ASIA-PACIFIC PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 106
• TABLE 62 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 106
• TABLE 63 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 106
• TABLE 64 ASIA-PACIFIC SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 107
• TABLE 65 ASIA-PACIFIC LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 107
• TABLE 66 ASIA-PACIFIC SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 107
• TABLE 67 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 108
• TABLE 68 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 108
• TABLE 69 CHINA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 109
• TABLE 70 CHINA ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 109
• TABLE 71 CHINA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 109
• TABLE 72 CHINA OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 110
• TABLE 73 CHINA MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 110
• TABLE 74 CHINA PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 110
• TABLE 75 CHINA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 111
• TABLE 76 CHINA CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 111
• TABLE 77 CHINA VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 111
• TABLE 78 CHINA VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 112
• TABLE 79 CHINA VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 112
• TABLE 80 CHINA COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 112
• TABLE 81 CHINA PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 113
• TABLE 82 CHINA VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 113
• TABLE 83 CHINA VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 113
• TABLE 84 CHINA SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 114
• TABLE 85 CHINA LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 114
• TABLE 86 CHINA SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 114
• TABLE 87 CHINA VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 115
• TABLE 88 CHINA VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 115
• TABLE 89 AUSTRALIA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 116
• TABLE 90 AUSTRALIA ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 116
• TABLE 91 AUSTRALIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 116
• TABLE 92 AUSTRALIA OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 117
• TABLE 93 AUSTRALIA MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 117
• TABLE 94 AUSTRALIA PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 117
• TABLE 95 AUSTRALIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 118
• TABLE 96 AUSTRALIA CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 118
• TABLE 97 AUSTRALIA VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 118
• TABLE 98 AUSTRALIA VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 119
• TABLE 99 AUSTRALIA VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 119
• TABLE 100 AUSTRALIA COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 119
• TABLE 101 AUSTRALIA PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 120
• TABLE 102 AUSTRALIA VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 120
• TABLE 103 AUSTRALIA VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 120
• TABLE 104 AUSTRALIA SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 121
• TABLE 105 AUSTRALIA LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 121
• TABLE 106 AUSTRALIA SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 121
• TABLE 107 AUSTRALIA VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 122
• TABLE 108 AUSTRALIA VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 122
• TABLE 109 INDIA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 123
• TABLE 110 INDIA ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 123
• TABLE 111 INDIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 123
• TABLE 112 INDIA OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 124
• TABLE 113 INDIA MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 124
• TABLE 114 INDIA PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 124
• TABLE 115 INDIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 125
• TABLE 116 INDIA CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 125
• TABLE 117 INDIA VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 125
• TABLE 118 INDIA VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 126
• TABLE 119 INDIA VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 126
• TABLE 120 INDIA COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 126
• TABLE 121 INDIA PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 127
• TABLE 122 INDIA VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 127
• TABLE 123 INDIA VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 127
• TABLE 124 INDIA SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 128
• TABLE 125 INDIA LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 128
• TABLE 126 INDIA SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 128
• TABLE 127 INDIA VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 129
• TABLE 128 INDIA VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 129
• TABLE 129 JAPAN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 129
• TABLE 130 JAPAN ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 130
• TABLE 131 JAPAN ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 130
• TABLE 132 JAPAN OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 131
• TABLE 133 JAPAN MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 131
• TABLE 134 JAPAN PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 131
• TABLE 135 JAPAN KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 132
• TABLE 136 JAPAN CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 132
• TABLE 137 JAPAN VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 132
• TABLE 138 JAPAN VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 133
• TABLE 139 JAPAN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 133
• TABLE 140 JAPAN COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 133
• TABLE 141 JAPAN PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 134
• TABLE 142 JAPAN VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 134
• TABLE 143 JAPAN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 134
• TABLE 144 JAPAN SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 135
• TABLE 145 JAPAN LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 135
• TABLE 146 JAPAN SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 135
• TABLE 147 JAPAN VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 136
• TABLE 148 JAPAN VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 136
• TABLE 149 SINGAPORE VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 137
• TABLE 150 SINGAPORE ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 137
• TABLE 151 SINGAPORE ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 137
• TABLE 152 SINGAPORE OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 138
• TABLE 153 SINGAPORE MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 138
• TABLE 154 SINGAPORE PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 138
• TABLE 155 SINGAPORE KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 139
• TABLE 156 SINGAPORE CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 139
• TABLE 157 SINGAPORE VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 139
• TABLE 158 SINGAPORE VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 140
• TABLE 159 SINGAPORE VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 140
• TABLE 160 SINGAPORE COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 140
• TABLE 161 SINGAPORE PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 141
• TABLE 162 SINGAPORE VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 141
• TABLE 163 SINGAPORE VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 141
• TABLE 164 SINGAPORE SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 142
• TABLE 165 SINGAPORE LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 142
• TABLE 166 SINGAPORE SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 142
• TABLE 167 SINGAPORE VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 143
• TABLE 168 SINGAPORE VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 143
• TABLE 169 INDONESIA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 144
• TABLE 170 INDONESIA ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 144
• TABLE 171 INDONESIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 144
• TABLE 172 INDONESIA OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 145
• TABLE 173 INDONESIA MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 145
• TABLE 174 INDONESIA PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 145
• TABLE 175 INDONESIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 146
• TABLE 176 INDONESIA CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 146
• TABLE 177 INDONESIA VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 146
• TABLE 178 INDONESIA VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 147
• TABLE 179 INDONESIA VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 147
• TABLE 180 INDONESIA COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 147
• TABLE 181 INDONESIA PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 148
• TABLE 182 INDONESIA VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 148
• TABLE 183 INDONESIA VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 149
• TABLE 184 INDONESIA SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 149
• TABLE 185 INDONESIA LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 149
• TABLE 186 INDONESIA SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 150
• TABLE 187 INDONESIA VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 150
• TABLE 188 INDONESIA VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 150
• TABLE 189 MALAYSIA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 151
• TABLE 190 MALAYSIA ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 151
• TABLE 191 MALAYSIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 151
• TABLE 192 MALAYSIA OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 152
• TABLE 193 MALAYSIA MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 152
• TABLE 194 MALAYSIA PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 152
• TABLE 195 MALAYSIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 153
• TABLE 196 MALAYSIA CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 153
• TABLE 197 MALAYSIA VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 153
• TABLE 198 MALAYSIA VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 154
• TABLE 199 MALAYSIA VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 154

• TABLE 200 MALAYSIA COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 154
• TABLE 201 MALAYSIA PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 155
• TABLE 202 MALAYSIA VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 155
• TABLE 203 MALAYSIA VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 155
• TABLE 204 MALAYSIA SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 156
• TABLE 205 MALAYSIA LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 156
• TABLE 206 MALAYSIA SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 156
• TABLE 207 MALAYSIA VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 157
• TABLE 208 MALAYSIA VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 157
• TABLE 209 NEW ZEALAND VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 158
• TABLE 210 NEW ZEALAND ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 158
• TABLE 211 NEW ZEALAND ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 158
• TABLE 212 NEW ZEALAND OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 159
• TABLE 213 NEW ZEALAND MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 159
• TABLE 214 NEW ZEALAND PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 159
• TABLE 215 NEW ZEALAND KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 160
• TABLE 216 NEW ZEALAND CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 160
• TABLE 217 NEW ZEALAND VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 160
• TABLE 218 NEW ZEALAND VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 161
• TABLE 219 NEW ZEALAND VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 161
• TABLE 220 NEW ZEALAND COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 161
• TABLE 221 NEW ZEALAND PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 162
• TABLE 222 NEW ZEALAND VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 162
• TABLE 223 NEW ZEALAND VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 163
• TABLE 224 NEW ZEALAND SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 163
• TABLE 225 NEW ZEALAND LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 163
• TABLE 226 NEW ZEALAND SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 164
• TABLE 227 NEW ZEALAND VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 164
• TABLE 228 NEW ZEALAND VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 164
• TABLE 229 SOUTH KOREA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 165
• TABLE 230 SOUTH KOREA ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 165
• TABLE 231 SOUTH KOREA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 165
• TABLE 232 SOUTH KOREA OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 166
• TABLE 233 SOUTH KOREA MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 166
• TABLE 234 SOUTH KOREA PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 166
• TABLE 235 SOUTH KOREA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 167
• TABLE 236 SOUTH KOREA CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 167
• TABLE 237 SOUTH KOREA VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 167
• TABLE 238 SOUTH KOREA VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 168
• TABLE 239 SOUTH KOREA VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 168
• TABLE 240 SOUTH KOREA COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 168
• TABLE 241 SOUTH KOREA PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 169
• TABLE 242 SOUTH KOREA VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 169
• TABLE 243 SOUTH KOREA VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 169
• TABLE 244 SOUTH KOREA SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 170
• TABLE 245 SOUTH KOREA LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 170
• TABLE 246 SOUTH KOREA SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 170
• TABLE 247 SOUTH KOREA VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 171
• TABLE 248 SOUTH KOREA VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 171
• TABLE 249 VIETNAM VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 172
• TABLE 250 VIETNAM ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 172
• TABLE 251 VIETNAM ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 172
• TABLE 252 VIETNAM OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 173
• TABLE 253 VIETNAM MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 173
• TABLE 254 VIETNAM PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 173
• TABLE 255 VIETNAM KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 174
• TABLE 256 VIETNAM CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 174
• TABLE 257 VIETNAM VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 174
• TABLE 258 VIETNAM VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 175
• TABLE 259 VIETNAM VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 175
• TABLE 260 VIETNAM COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 175
• TABLE 261 VIETNAM PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 176
• TABLE 262 VIETNAM VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 176
• TABLE 263 VIETNAM VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 176
• TABLE 264 VIETNAM SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 177
• TABLE 265 VIETNAM LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 177
• TABLE 266 VIETNAM SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 177
• TABLE 267 VIETNAM VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 178
• TABLE 268 VIETNAM VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 178
• TABLE 269 THAILAND VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 179
• TABLE 270 THAILAND ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 179
• TABLE 271 THAILAND ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 179
• TABLE 272 THAILAND OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 180
• TABLE 273 THAILAND MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 180
• TABLE 274 THAILAND PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 180
• TABLE 275 THAILAND KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 181
• TABLE 276 THAILAND CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 181
• TABLE 277 THAILAND VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 181
• TABLE 278 THAILAND VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 182
• TABLE 279 THAILAND VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 182
• TABLE 280 THAILAND COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 182
• TABLE 281 THAILAND PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 183
• TABLE 282 THAILAND VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 183
• TABLE 283 THAILAND VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 183
• TABLE 284 THAILAND SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 184
• TABLE 285 THAILAND LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 184
• TABLE 286 THAILAND SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 184
• TABLE 287 THAILAND VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 185
• TABLE 288 THAILAND VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 185
• TABLE 289 PHILIPPINES VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 186
• TABLE 290 PHILIPPINES ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 186
• TABLE 291 PHILIPPINES ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 186
• TABLE 292 PHILIPPINES OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 187
• TABLE 293 PHILIPPINES MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 187
• TABLE 294 PHILIPPINES PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 187
• TABLE 295 PHILIPPINES KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 188
• TABLE 296 PHILIPPINES CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 188
• TABLE 297 PHILIPPINES VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 188
• TABLE 298 PHILIPPINES VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 189
• TABLE 299 PHILIPPINES VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 189
• TABLE 300 PHILIPPINES COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 189
• TABLE 301 PHILIPPINES PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 190
• TABLE 302 PHILIPPINES VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 190
• TABLE 303 PHILIPPINES VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 190
• TABLE 304 PHILIPPINES SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 191
• TABLE 305 PHILIPPINES LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 191
• TABLE 306 PHILIPPINES SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 191
• TABLE 307 PHILIPPINES VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 192
• TABLE 308 PHILIPPINES VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 192
• TABLE 309 TAIWAN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 193
• TABLE 310 TAIWAN ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 193
• TABLE 311 TAIWAN ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 193
• TABLE 312 TAIWAN OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 194
• TABLE 313 TAIWAN MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 194
• TABLE 314 TAIWAN PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 194
• TABLE 315 TAIWAN KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 195
• TABLE 316 TAIWAN CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 195
• TABLE 317 TAIWAN VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 195
• TABLE 318 TAIWAN VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 196
• TABLE 319 TAIWAN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 196
• TABLE 320 TAIWAN COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 196
• TABLE 321 TAIWAN PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 197
• TABLE 322 TAIWAN VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 197
• TABLE 323 TAIWAN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 197
• TABLE 324 TAIWAN SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 198
• TABLE 325 TAIWAN LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 198
• TABLE 326 TAIWAN SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 198
• TABLE 327 TAIWAN VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 199
• TABLE 328 TAIWAN VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 199
• TABLE 329 REST OF ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 200

LIST OF FIGURES

• FIGURE 1 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: SEGMENTATION 32
• FIGURE 2 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: DATA TRIANGULATION 35
• FIGURE 3 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: DROC ANALYSIS 36
• FIGURE 4 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS 37
• FIGURE 5 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: COMPANY RESEARCH ANALYSIS 37
• FIGURE 6 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: INTERVIEW DEMOGRAPHICS 38
• FIGURE 7 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: MARKET END USER COVERAGE GRID 39
• FIGURE 8 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: DBMR MARKET POSITION GRID 41
• FIGURE 9 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: VENDOR SHARE ANALYSIS 42
• FIGURE 10 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: SEGMENTATION 46
• FIGURE 11 INCREASING PET OWNERSHIP AND ADVANCEMENTS IN VETERINARY MEDICINE ARE EXPECTED TO DRIVE THE GROWTH OF THE ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET FROM 2023 TO 2030 47
• FIGURE 12 THE ANALGESICS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET IN 2023 & 2030 47
• FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES FOR ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET 52
• FIGURE 14 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: BY PRODUCT TYPE, 2022 60
• FIGURE 15 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: BY DRUG TYPE, 2022 69
• FIGURE 16 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: BY MODE OF PURCHASE, 2022 72
• FIGURE 17 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: BY ANIMAL TYPE, 2022 75
• FIGURE 18 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: BY PAIN SOURCE, 2022 80
• FIGURE 19 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: BY DOSAGE, 2022 85
• FIGURE 20 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: BY ROUTE OF ADMINISTRATION, 2022 91
• FIGURE 21 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: BY END USER, 2022 95
• FIGURE 22 ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET: COMPANY SHARE 2022 (%) 201